Skip to content

“Negami” an app for active exploration training with augmented reality for patients with unilateral neglect after stroke- a randomized controlled trial

“Negami” an app for active exploration training with augmented reality for patients with unilateral neglect after stroke- a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00031446
Enrollment
20
Registered
2023-03-08
Start date
2021-10-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spatial Neglect

Interventions

Group 1: Negami therapy group: two weeks with 5 sessions/week of 20-25 minutes each. Group 2: Standard Neglect therapy group: two weeks with 5 sessions/week of 20-30 minutes each.

Sponsors

Universitätsklinikum Tübingen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: The inclusion criterion for this study was the presence of spatial neglect. In addition to clinical behavioral observations, diagnostic criteria had to be met in at least two of the following four neglect tests: The Letter Cancellation Test (Weintraub & Mesulam, 1987), the Bells Test (Gauthier et al., 1989), a Copying Task (Johannsen & Karnath, 2004), and a Line Bisection Task (McIntosh et al., 2005).

Exclusion criteria

Exclusion criteria: Patients with tumors or patients in whom scans (CT/MRI) showed no obvious lesions were excluded.

Design outcomes

Primary

MeasureTime frame
- What: Improvement of Neglectsymptomatics. - When: both groups weekly over a 5-week period; Negami therapy group received a 6th examination 1-2 months after completion of therapy - How: Performance assessment was via neglect diagnostics: Letter Cancellation, Bells Cancellation, Copying task, Line Bisection, and a self developed task measuring active exploratory behavior using a tablet

Countries

Germany

Contacts

Public ContactHans-Otto Karnath

Universitätsklinikum Tübingen

karnath@uni-tuebingen.de+497071 29-80476

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026